Anticoagulation Management in Individuals with Hip Fracture

Anticoagulation Management in Individuals with Hip Fracture

Objectives To determine the interventions taken to lower international normalized ratio (INR) in individuals with hip fracture using warfarin before admission for hip fracture surgery in a geriatric fracture center (GFC) and compare outcomes with those of individuals not taking warfarin. Design Coho...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Geriatrics Society (JAGS) 2014-01, Vol.62 (1), p.159-164
Hauptverfasser: Gleason, Lauren J., Mendelson, Daniel A., Kates, Stephen L., Friedman, Susan M.
Format: Artikel
Sprache:eng
Schlagworte:
Aged
Aged, 80 and over
Anticoagulants
Anticoagulants - therapeutic use
anticoagulation
Biological and medical sciences
co-management
Comorbidity
Female
Fractures
General aspects
hip fracture
Hip Fractures - mortality
Hip Fractures - surgery
Hip joint
Hospital Mortality
Humans
International Normalized Ratio
Joint surgery
Length of Stay - statistics & numerical data
Male
Medical sciences
Middle Aged
Miscellaneous
Older people
Patient Readmission - statistics & numerical data
Postoperative Complications - mortality
Public health. Hygiene
Public health. Hygiene-occupational medicine
Retrospective Studies
transfusion
Treatment Outcome
Warfarin - therapeutic use
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives To determine the interventions taken to lower international normalized ratio (INR) in individuals with hip fracture using warfarin before admission for hip fracture surgery in a geriatric fracture center (GFC) and compare outcomes with those of individuals not taking warfarin. Design Cohort study using retrospective chart review. Setting University‐affiliated community teaching hospital. Participants Individuals aged 60 and older admitted to a GFC for surgical repair of a nonpathological, nonperiprosthetic hip fracture between April 2006 and April 2012. Measurements Descriptive data collected from a quality improvement registry with additional information for individuals taking warfarin obtained from chart review. Results Of the 1,080 individuals included in the analysis, 84 (7.8%) were taking warfarin on admission. Participants using warfarin had a higher average Charlson Comorbidity Index (3.8 vs 3.1, P 
ISSN:0002-8614
1532-5415
DOI:10.1111/jgs.12591